Bulnesia sarmienti, ext.

Endpoint summary

Description of key information

Skin sensitisation: sensitising (OECD 429)

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

18-12-2015 to 25-03-2016

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Remarks:

in accordance with GLP

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

Qualifier:

according to guideline

Guideline:

EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.2600 (Skin Sensitisation)

Deviations:

no

GLP compliance:

yes

Type of study:

mouse local lymph node assay (LLNA)

Species:

mouse

Strain:

CBA

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: approximately 10 weeks old
- Weight at study initiation: body weight variation was within +/- 20% of the sex mean
- Housing: labeled Makrolon cages containing sterilised sawdust as bedding material. Paper and shelters were supplied as cage-enrichment
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days before the start of treatment under laboratory conditions

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24°C
- Humidity (%): 40 to 70%
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12 hrs dark/ 12 hrs light

Vehicle:

acetone/olive oil (4:1 v/v)

Concentration:

Pre-screen test: 50 - 100%Main study: 0 - 25 - 50 -100 % (v/v)

No. of animals per dose:

5

Details on study design:

MAIN STUDY

ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: Increased T-lymphocyte proliferation in the test groups as compared to the concurrent vehicle control group.

EVALUATION
The disintegrations per minute (dpm) value was determined for each test group. This information was used to calculate the Stimulation Index (SI) for each of the test groups (disintegrations per minute of treatment group / disintegrations per minute of control group). A positive response is indicated when one or more test groups shows a SI of 3. The EC3 value is the concentration at which a 3-fold increase of lymph node proliferation is observed. Interpolation is used to determine the EC3 value between two test concentrations (based on the following reference: Basketter DA, Lea LJ, Dickens A, Briggs, D, Pate I, Dearman RJ and Kimber I.A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J Appl Toxicol 1999; 19:261-266

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Positive control results:

The six monthly reliability check with Hexylcinnamaldehyde, indicates that the Local Lymph Node Assay as performed at WIL Research Europe is an appropriate model for testing for contact hypersensitivity.

Key result

Parameter:

EC3

Value:

42.6

Parameter:

SI

Value:

1.8

Test group / Remarks:

25%

Parameter:

SI

Value:

3.5

Test group / Remarks:

50%

Parameter:

SI

Value:

4.4

Test group / Remarks:

100%

Cellular proliferation data / Observations:

CELLULAR PROLIFERATION DATA
Mean DPM/animal values for the experimental groups treated with test substance concentrations 25, 50 and 100% were 1116, 2158 and 2746 DPM respectively.
The mean DPM/animal value for the vehicle control group was 623 DPM.

DETAILS ON STIMULATION INDEX CALCULATION
The Stimulation Index was calculated as a ratio of the DPM from test groups and the DPM vehicle control group (DPM test group / DPM vehicle control group).

EC3 CALCULATION
The data showed a dose-response relationship and an EC3 value (the estimated test substance concentration that will give a SI =3) of 42.6% was calculated.

CLINICAL OBSERVATIONS:
The results of the LLNA study showed that no irritation was observed in any of the animals. Scaliness was noted for three animals treated at 50% and all animals treated at 100% on Day 6. The relative size of the auricular lymph nodes of all animals of the experimental and control groups were considered normal in size. There was no mortality, neither where there any clinical signs of systemic toxicity.

BODY WEIGHTS
Body weights and body weight gain of experimental animals remained in the same range as controls over the study period.

Pre-screen test: The results of the epidermal exposures for the selection of highest test substance concentration show that there was no clear irritation detected, apart from very slight erythema (barely perceptible). Based on these results, the highest test substance concentration selected for the main study was a 100% concentration.

Interpretation of results:

Category 1B (indication of skin sensitising potential) based on GHS criteria

Conclusions:

Under the conditions of this test, the test substance was found to elicit a positive response (SI ≥ 3) and a clear dose-response relationship was found. The EC3 value was calculated to be 42.6%. Based on these results, Guaiacwood oil needs to be classified for skin sensitization (H317, Skin Sens. 1B) in accordance with the criteria outlined in Annex I of CLP (1272/2008/EC).

Executive summary:

The Local Lymph Node Assay (according to OECD 429) was conducted to determine the sensitising potential of Guaiacwood oil in mice. Lymph node proliferation was determined after exposure to 0%, 25%, 50% or 100% Guaiacwood oil in vehicle (Acetone/Olive oil (4:1 v/v)), using radioactivity counts (DPM). A pooled approach (per test group) was used. Stimulation indices were calculated.

 

Measured disintegrations per node (pooled) were 623, 1116, 2158 and 2746 for the 0%, 25%, 50% and 100% dosing groups, respectively. Corresponding stimulation indices (SI) were calculated to be 1.8, 3.5 and 4.4 for the 25%, 50% and 100% concentration, respectively. The EC3 was calculated to be 42.6%. Based on these results, Guaiacwood oil needs to be classified for skin sensitization (H317, Skin Sens. 1B) in accordance with the criteria outlined in Annex I of CLP (1272/2008/EC).

Endpoint conclusion

Endpoint conclusion:

adverse effect observed (sensitising)

Additional information:

The key study is a local lymph node assay (LLNA) performed with Guaiacwood oil (OECD 429, GLP). Measured disintegrations per node (pooled) were 623, 1116, 2158 and 2746 for the 0%, 25%, 50% and 100% dosing groups, respectively. Corresponding stimulation indices (SI) were calculated to be 1.8, 3.5 and 4.4 for the 25%, 50% and 100% concentration, respectively. Based on these results, the EC3 was calculated to be 42.6% and hence the substance should be considered a skin sensitizer.

Respiratory sensitisation

Endpoint conclusion

Endpoint conclusion:

no study available

Justification for classification or non-classification

Based on the result of the key study (EC3 value: 42.6%), Guaiacwood oil needs to be classified for skin sensitization (H317, Skin Sens. 1B) in accordance with the criteria outlined in Annex I of 1272/2008/EC (CLP).